Optical coherence tomography as a potential readout in clinical trials.
about
Optical coherence tomography as a biomarker in multiple sclerosis.Retinal imaging as a source of biomarkers for diagnosis, characterization and prognosis of chronic illness or long-term conditionsVessel labeling in combined confocal scanning laser ophthalmoscopy and optical coherence tomography images: criteria for blood vessel discrimination.Evaluation of the retinal changes in patients with chronic migraine.Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosisThe use of time-lapse optical coherence tomography to image the effects of microapplied toxins on the retina.Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson's diseaseAdvancing therapeutic options in multiple sclerosis with neuroprotective properties.Three-dimensional imaging technologies: a priority for the advancement of tissue engineering and a challenge for the imaging community.Secondary Progressive Multiple Sclerosis: Definition and Measurement.Retinal and Cortical Blood Flow Dynamics Following Systemic Blood-Neural Barrier DisruptionOptical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression.Optical Coherence Tomography: Basic Concepts and Applications in Neuroscience Research.
P2860
Q30597564-77D229DA-A6C0-4346-8FEB-B123A3A971C5Q33956257-027D8D35-3A32-4483-959D-7C8DA5B2FA76Q34155509-D1B652FF-4567-4AB0-9613-3CA9EC565C51Q34470699-6CF423DE-E2C3-4C24-BC21-08BBCF1B8539Q34992546-EDFD7B53-EF2A-49D8-9128-408B5D59720DQ35981274-C5C81D0D-B6F6-42B8-8465-B6AE75F34016Q36686111-29A74135-B2D1-4C59-A28C-AD63A11F8489Q38110475-1051C88B-EFC9-411F-9060-C811E85AAC71Q38816455-6AC8A792-2F87-40E3-AE78-378C3244BFB0Q38831720-0FC2CD45-0B88-445B-BACD-654C46677D5CQ42694289-BC4F7010-8694-4310-9752-A7B930F728A8Q45289374-F94E6571-83AF-4C96-BF33-7414D3E96674Q47111317-D52E2FB3-C508-4541-BE60-47D649897634
P2860
Optical coherence tomography as a potential readout in clinical trials.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Optical coherence tomography as a potential readout in clinical trials.
@en
type
label
Optical coherence tomography as a potential readout in clinical trials.
@en
prefLabel
Optical coherence tomography as a potential readout in clinical trials.
@en
P2860
P356
P1476
Optical coherence tomography as a potential readout in clinical trials.
@en
P2093
Benjamin M Greenberg
Elliot Frohman
P2860
P304
P356
10.1177/1756285610368890
P577
2010-05-01T00:00:00Z